drugset / Trial / NCT01128556

The Evaluation of Bepreve on the Measurement of Wheal and Flare Response From Histamine Skin Prick Testing

NCT01128556

Phase 4 Completed 30 enrolled North Texas Institute for Clinical Trials
Non-randomizedCrossoverOpen-label

Summary

To evaluate the effect of BEPREVE compared to a REFRESH Tears Lubricant eye drop on the measurement of the wheal and flare from histamine skin prick testing. This is an open label, two-week, post-marketing study conducted on histamine responsive patients.

Timeline

Start
2010-04
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Bepotastine Small molecule 1.5 % Topical
Subject Refresh Tears Unknown Topical

Indications